Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Clofarabine | Clofarabine beta-Pyranosyl Formamide Impurity | VE008549 | View CAS 1140251-33-7 |
Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Clofarabine | Clofarabine beta-Pyranosyl Formamide Impurity | VE008549 | View CAS 1140251-33-7 |
Catalogue No. | VE008549 |
CAS No. | 1140251-33-7 |
Molecular Formula | C10H13ClFN5O4 |
Molecular Weight | 321.69 g/mol |
Parent drug | Clofarabine |
IUPAC Name | N-(4-Amino-2-chloro-6-((2R, 3R, 4R, 5R)-3-fluoro-4, 5-dihydroxy-tetrahydro-2H-pyran-2-ylamino)pyrimidin-5-yl)formamide |
Synonyms | N/A |
References | Ghanem, H., Kantarjian, H., Ohanian, M., & Jabbour, E. (2012). The role of clofarabine in acute myeloid leukemia. Leukemia & Lymphoma, 54(4), 688–698. https://doi.org/10.3109/10428194.2012.726722 |
Status | In-stock |
ListName | Clofarabine beta-Pyranosyl Formamide Impurity |
Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields